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Huntington’s disease (HD) is a neurodegenerative disorder characterized by deficits in
movement control that are widely viewed as stemming from pathophysiological changes
in the striatum. Giant, aspiny cholinergic interneurons (ChIs) are key elements in the
striatal circuitry controlling movement, but whether their physiological properties are
intact in the HD brain is unclear. To address this issue, the synaptic properties of ChIs
were examined using optogenetic approaches in the Q175 mouse model of HD. In
ex vivo brain slices, synaptic facilitation at thalamostriatal synapses onto ChIs was
reduced in Q175 mice. The alteration in thalamostriatal transmission was paralleled
by an increased response to optogenetic stimulation of cortical axons, enabling these
inputs to more readily induce burst-pause patterns of activity in ChIs. This adaptation
was dependent upon amplification of cortically evoked responses by a post-synaptic
upregulation of voltage-dependent Na+ channels. This upregulation also led to an
increased ability of somatic spikes to invade ChI dendrites. However, there was not an
alteration in the basal pacemaking rate of ChIs, possibly due to increased availability
of Kv4 channels. Thus, there is a functional “re-wiring” of the striatal networks in
Q175 mice, which results in greater cortical control of phasic ChI activity, which is widely
thought to shape the impact of salient stimuli on striatal action selection.
Keywords: channelrhodopsin-2, parafascicular nucleus, glutamatergic transmission, A-type K+ current,
persistent Na+ current, ranolazine, paired-pulse ratio, minimal stimulation
INTRODUCTION
Huntington’s disease (HD) is an autosomal–dominant, progressive neurodegenerative disease
associated with an expanded CAG repeat in the huntingtin (Htt) gene (Zuccato et al., 2010).
Consistent with the prominent motor symptoms of the disease, there are clear pathological changes
in the basal ganglia circuitry influencing goal directed movement and habit. In the striatum—the
largest of the basal ganglia nuclei—principal spiny projection neurons (SPNs) atrophy (Deng et al.,
2004). Recent work suggests that the atrophy of SPNs is due in part to impaired brain derived
neurotrophic factor signaling through TrkB receptors (Canals et al., 2004; Plotkin et al., 2014).
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Although mutant Htt (mHtt) profoundly affects SPNs (Deng
et al., 2004; André et al., 2011) it also alters the properties of
interneurons that modulate the striatal circuitry. Giant, aspiny
cholinergic interneurons (ChIs) are key regulators of both SPN
synaptic integration and intrinsic excitability (Kemp and Powell,
1971; Bolam et al., 1984; Wilson et al., 1990; Tepper and
Bolam, 2004). Indices of striatal cholinergic signaling decline
in the HD brain and in the brain of mouse models of the
disease. Evoked acetylcholine (ACh) release is reduced (Farrar
et al., 2011), as is the abundance of choline acetyltransferase,
vesicular ACh transporters and muscarinic receptors (Cha
et al., 1998; Smith et al., 2006). What is less clear is whether
the physiological properties of ChIs are altered by mHtt in
parallel.
ChIs are pacemaking neurons whose regular spiking is
modulated by synaptic input (Bennett and Wilson, 1999). Both
anatomical (Lapper and Bolam, 1992) and physiological (Ding
et al., 2010; Threlfell et al., 2012; Doig et al., 2014) evidence
suggests that although they receive cortical glutamatergic input,
the intralaminar nuclei (ILN) of the thalamus provide the
predominant source of extrinsic excitatory input to ChIs (Sidibe
and Smith, 1999; Ding et al., 2010). This feature of ChIs might
be critical to the pathophysiology of HD. In the disease, ILN
neurons are lost (Heinsen et al., 1996; Kassubek et al., 2005). In
the Q140 ‘‘knockin’’ mouse model of HD, there are fewer large
axodendritic thalamostriatal terminals at presymptomatic ages
(Deng et al., 2013), reportedly due to a reduction in dendritic
branching in ChIs (Deng and Reiner, 2016). If the thalamic
innervation of ChIs is reduced, their activation by behaviorally
relevant stimuli, which depends upon the ILN, could be impaired
(Matsumoto et al., 2001). This could have a wide range of
deleterious effects on the striatal processing of movement related
signals, including those arising from the cerebral cortex (Ding
et al., 2010).
The studies described here examined the physiological
properties of ChIs in presymptomatic (2–6 month old)
Q175 heterozygous mice. It was found that thalamostriatal
synaptic transmission to ChIs was altered in Q175 tissue,
losing its facilitating response to repetitive stimulation. In
addition, ChIs became significantly more responsive to strong
optogenetic activation of corticostriatal inputs. The amplification
of the corticostriatal synaptic currents was mediated by a
post-synaptic, upregulation of voltage-dependent Na+ channels.
This adaptation was apparently restricted to dendrites, as
autonomous discharge of ChIs remained unchanged, whereas
back-propagating action potentials (bAPs) reached more distal
dendritic arbors in the ChIs from Q175 mice. Thus, our results
suggest that there is a functional ‘‘re-wiring’’ of the networks
controlling striatal ChI activity, which becomes more attuned to
cortical input in HD.
MATERIALS AND METHODS
Animals
This study was carried out in accordance with the
recommendations of and approved by Northwestern University
and the Hebrew University Animal Care and Use Committees.
All of the experiments were conducted with 2–6 month old
heterozygous Q175 male mice (Q175+/−) and their wildtype
(WT) littermates on a C57Bl/6 background.
Cortical Expression of ChR2
To investigate corticostriatal transmission to ChIs,
homozygous transgenic mice [B6.Cg-Tg (Thy1-COP4/EYFP)
18Gfng/1] expressing channelrhodopsin-2 (ChR2) under the
Thy1 promoter (Arenkiel et al., 2007) were crossed with
Q175 mice (Menalled et al., 2003; Zuccato et al., 2010). In
this particular line of Thy1-ChR2 mice, there is a robust
expression of ChR2 in cortical pyramidal neurons, but little or no
expression in thalamic nuclei projecting to the striatum, allowing
optogenetic approaches to be used to study corticostriatal
synaptic transmission.
Thalamic Expression of ChR2
Bilateral stereotaxic injections into caudal ILN of thalamus
were performed using standard approaches. AAV serotype
2/9 carrying fusion genes for hChR2 (H134R) and mCherry
under CAG promoter (AAV-ChR2, University of Pennsylvania
Vector Core, Addgene #20938MOD), were used to transfect
parafascicular nuclei (PFN) neurons. Injection coordinates that
target PFN (Ellender et al., 2013), which is thought to be the
major source of thalamic inputs to ChIs (Lapper and Bolam,
1992; Ding et al., 2010; Threlfell et al., 2012), were identified
using the Angle Two software (Leica, Buffalo Grove, IL, USA)
and were from Bregma: lateral, 0.72 mm; posterior, 2.4 mm;
and 3.5 mm depth from surface of brain. Briefly, stereotaxic
surgeries were performed on mice anesthetized with isoflurane.
A small hole was bored into the skull with a micro drill bit and
a glass pipette was slowly inserted at the PFN coordinates. To
minimize backflow, solution was slowly injected; a total volume
of 0.1–0.3µl (>5× 1012 GC) of the AAV constructs was injected
over 1 min and the electrode was left in place for 10 min before
slowly retracting it. Topical analgesics were applied to the skin
around the suture (Lidocaine 2.5% and Prilocaine 2.5% cream)
and subcutaneous injections of 1 mg/kg of 0.9% saline solution
and analgesic Metacam 2% or Carpofen (5 mg/kg) were given.
Two to 3 weeks after viral injections (which was an optimal time
window for viral expression under the CAG promoter), mice
were used for experiments.
Slice Preparation
Animals were deeply anesthetized with ketamine–xylazine
and perfused transcardially with ice-cold modified artificial
cerebrospinal fluid (ACSF), bubbled with 95% O2-5% CO2, and
containing (in mM): 2.5 KCl, 26 NaHCO3, 1.25 Na2HPO4,
0.5 CaCl2, 10 MgSO4, 0.4 ascorbic acid, 10 glucose, and
210 sucrose. The brain was removed and blocked in the sagittal
plane and sectioned at a thickness of 275µm in ice-coldmodified
ACSF. Slices were then submerged in ACSF, bubbled with
95% O2-5% CO2, and containing (in mM): 2.5 KCl, 126 NaCl,
26 NaHCO3, 1.25 Na2HPO4, 2 CaCl2, 2 MgSO4, and 10 glucose,
and stored at room temperature for at least 1 h prior to
recording.
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Slice Visualization, Electrophysiology and
Optical Stimulation
The slices were transferred to the recording chamber mounted
on an Olympus BX51 upright, fixed-stage microscope and
perfused with oxygenated ACSF at 32◦C. A 60×, 0.9 NA water-
immersion objective was used to examine the slice using standard
infrared differential interference contrast video microscopy.
Patch pipette resistance was typically 3–4.5 M when filled
with recording solutions. In voltage-clamp experiments the
intracellular solution contained (in mM): 127.5 CsCH3SO3,
7.5 CsCl, 10 HEPES, 10 TEA-Cl, 4 phosphocreatine disodium,
0.2 EGTA, 0.21 Na2GTP and 2 Mg1.5ATP (pH = 7.3 with
CsOH, 280–290 mOsm/kg). In some experiments (e.g., paired-
pulse ratio (PPR) measurements), the pipette contained 5 mM
QX-314 bromide, as well. To record A-type hyperpolarization
activated transient outward K+ currents the electrodes were
filled with an intracellular solution containing (in mM):
135.5 KCH3SO4, 5 KCl, 2.5 NaCl, 10 HEPES, 0.2 EGTA,
5 phosphocreatine disodium, 0.21 Na2GTP and 2 Mg1.5ATP. For
whole-cell current clamp recordings the pipette contained (in
mM): 135.5 KCH3SO4, 5 KCl, 2.5 NaCl, 5 Na-phosphocreatine,
10 HEPES, 0.2 EGTA, 0.21 Na2GTP, and 2 Mg1.5ATP
(pH = 7.3 with KOH, 280–290 mOsm/kg). For two-photon laser
scanning microscopy (2PLSM) calcium imaging experiments
the pipette contained (in mM): 135 KCH3SO4, 5 KCl,
5 Na-phosphocreatine, 5 Tris-phosphocreatine, 10 HEPES,
0.1 Fluo-4, 0.025 Alexa Fluor 568, 0.21 Na2GTP, and 2Mg1.5ATP
(pH = 7.3 with KOH, 280–290 mOsm/Kg).
Electrophysiological recordings were obtained with a
Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA,
USA). Junction potential, which was 7–8 mV, was not corrected.
Signals were digitized at 20–100 kHz and logged onto a personal
computer with the Clampex 9.2 software (Molecular Devices).
Blue light LED (470 nm, model M470L2, Thor Labs, Newton,
NJ, USA or pE-100, CoolLED, Yorktown Heights, NY, USA)
was used for full-field illumination via the objective (LED power
was 1–19 mW). Single pulses were 1 ms long, pulse trains were
10 pulses long at 10 or 20 Hz.
2PLSM Imaging
The 2PLSM system was described previously (Guzman et al.,
2010; Goldberg et al., 2012). Briefly, the two-photon excitation
source was a Chameleon Ultra 2 tunable laser system
(680–1080 nm; Coherent Laser Group, Santa Clara, CA, USA).
Optical signals were acquired using an 810 nm excitation
beam to excite Alexa and Fluo-4 dyes simultaneously. Laser
power attenuation was achieved with two Pockels cells electro-
optic modulators (models 350–50 and 350–80, Conoptics,
Danbury, CT, USA). The fluorescence emission was collected
with non-descanned photomultiplier tubes (PMTs; Prairie
Technologies, Madison, WI, USA). A Dodt contrast detector
system was used to provide a bright-field transmission image in
registration with the fluorescent images. Scanning parameters:
pixel size was 0.08 µm, dwell time: 10 µs. At the end of the
experiment Z-series were acquired with pixel size: 0.36 µm and
dwell time: 6 µs (Day et al., 2008).
Drugs and Reagents
All experiments (except for measurements of tetrodotoxin
(TTX)-sensitive currents) were conducted with a cocktail of
synaptic blockers for ACh and GABA receptors including (in
µM): 10 atropine, 10 mecamylamine, 2 CGP 55845, 10 SR
95531 and 50 D-APV. The fast inactivating sodium current
was antagonized with TTX (1 µM), the persistent (‘‘late’’) Na+
current was antagonized with 30 µM ranolazine (Bennett et al.,
2000; Abrams et al., 2006) and Cav1 calcium channels were
blocked with 5 µM isradipine. All drugs and reagents were
acquired from Tocris (Ellisvile, MO, USA) or Sigma (St. Louis,
MO, USA), except for TTX that was acquired from Alomone lab
(Jerusalem, Israel). Fluo-4 (Invitrogen, Carlsbad, CA, USA) and
Alexa 568 (Invitrogen) were used to fill ChIs.
Data Analysis and Statistics
Data were analyzed and curve fitting was done using
custom-made code in Matlab (Mathworks, Natick, MA,
USA). The nonparametric two-tailed Wilcoxon rank-sum test
was used for independent samples, and the nonparametric
two-tailed Wilcoxon signed-rank test was used for matched
samples. Boxplots represent range (whiskers), median (thick
bar) and lower and upper quartiles. In the current-voltage and
current-LED intensity curves the medians of each measurement
are presented with confidence intervals given by the 50% ×
(1 ± 1/√n) percentiles, where n is the sample size (Lasser-Katz
et al., in press). The parametric ANCOVA test was used to
test significant changes in these curves. Null hypotheses were
rejected if the P-value was below 0.05.
RESULTS
Functional Properties of Thalamic
Synapses on ChIs were Modestly Altered
in Q175 Mice
Recent work has suggested that the thalamic innervation
of the striatum is reduced in HD models (Deng et al.,
2013; Deng and Reiner, 2016). This innervation arises
from the PFN of the thalamus (Lapper and Bolam, 1992;
Consolo et al., 1996; Sidibe and Smith, 1999; Matsumoto
et al., 2001; Bradfield et al., 2013). To study the impact
of mHtt on this projection, the physiological properties of
thalamostriatal synapses on ChIs in presymptomatic, 2–6 month
old heterozygous Q175 (Q175+/−) and WT mice were
examined. Visually identified ChIs invariably had prototypical
morphological (Figure 1A) and electrophysiological features,
including autonomous pacemaking, voltage sag in response to
hyperpolarization, and slow afterhyperpolarizations following
a long depolarization (Figure 1B; Kawaguchi, 1993; Bennett
and Wilson, 1999). In these presymptomatic mice, there were
no obvious morphological changes or alterations in basic
electrophysiological properties of ChIs, in agreement with recent
work in the R6/2 HD model (Holley et al., 2015).
To determine if there were functional changes in the
thalamic innervation of ChIs, optogenetic approaches were
used. Stereotaxic injection of AAV carrying a ChR2 expression
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FIGURE 1 | Morphology and firing patterns of cholinergic interneurons
(ChIs) in the Q175 mouse. (A) Z-axis projection of an Alexa 568 filled ChI
from a Q175+/− (heterozygous) mouse imaged with 2PLSM. (B) ChI
responses to long depolarizing and hyperpolarizing pulses in Q175+/− and
wildtype mice.
construct into the PFN (Figure 2A) led to robust excitatory
postsynaptic currents (EPSCs) in ChIs in response to optical
stimulation (Ellender et al., 2013; Parker et al., 2016). As shown
previously (Ding et al., 2010), these synaptic connections were
facilitating (increasing in amplitude with repetition; Figure 2B).
The degree of synaptic facilitation was measured by computing
the PPR, which was defined as the ratio of the amplitude
of the second EPSC divided by the first one. PPRs were
significantly reduced in 4–6 month old Q175 mice (WT median:
1.40, n = 15 neurons, N = 3 mice; Q175+/− median: 1.07,
n = 14 neurons, N = 3 mice, P < 0.01, two tailed Wilcoxon
rank-sum test, Figure 2B). The aggregate strength of the PF
innervation of ChIs could not be reliably assessed because of
variability in the extent of PF infection by the AAV carrying the
ChR2 expression construct.
The Response to Strong Cortical
Excitation was Elevated in Q175 ChIs
Glutamatergic pyramidal neurons in the cerebral cortex also
innervate striatal ChIs (Lapper and Bolam, 1992; Sidibe and
Smith, 1999; Thomas et al., 2000; Ding et al., 2010; Doig
et al., 2014; Kosillo et al., 2016). To determine if corticostriatal
synapses on ChIs were affected by mHtt, Q175 mice were
crossed with a transgenic mouse expressing ChR2 throughout
the cerebral cortex (Arenkiel et al., 2007). Unlike the situation
with AAV-dependent ChR2 expression, this transgenic model
yielded a consistent pattern and level of ChR2 expression.
Moreover, it allowed spatially distributed cortical inputs to ChIs
to be reliably stimulated. In these mice, the yellow fluorescent
protein (YFP) reporter of ChR2 expression was absent in the
thalamus, but was robust in the cortex (Figure 2C). Optogenetic
approaches were used to activate cortical axons in ex vivo
brain slices while recording from ChIs. As suggested previously,
the cortically PPR in ChIs was depressing (Ding et al., 2010).
This relationship was unchanged in 3–6-month old Q175 mice
(WT median: 0.85, n = 7 neurons, N = 2 mice; Q175+/−
FIGURE 2 | Light-driven paired-pulse ratios (PPRs) of thalamo- and cortico-striatal synapses onto ChIs in the Q175 mouse. (A) Sagittal section with the
site of AAV-ChR2 transfection visible in the thalamus and axonal expression in the striatum. (B) Left: examples of trains of optogenetically induced thalamostriatal
excitatory postsynaptic currents (EPSCs; 10 Hz) in wildtype (WT), (black trace) and Q175+/− (gray) mice. Inset: schematic of optogenetic stimulation of
thalamostriatal axons; Right: boxplot of thalamostriatal PPR values in both genotypes (measured using the first two EPSCs in the train as illustrated by the gray
background). (C) Sagittal cortical section in Thy1-ChR2 mice. (D) Left: examples of trains of optogenetically induced corticostriatal EPSCs in WT mice. Inset:
schematic of optogenetic stimulation of corticostriatal axons; Right: boxplot of corticostriatal PPR values in both genotypes.
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median: 0.86, n = 4 neurons, N = 1 mouse, P > 0.75, two
tailed Wilcoxon rank-sum test, Figure 2D), suggesting that there
was no alteration in glutamate release probability from cortical
terminals in Q175 mice.
Minimal local optical stimulation was used to evoke unitary
EPSCs in ChIs (Higley et al., 2009). The probability density
function of the response amplitude was estimated and then
fit with the sum of two Gaussian distributions (Redman,
1990). The fits to the 4-month old WT and Q175 mice
were very similar, sharing a 2nd mode, indicating that
the individual synaptic responses were also unchanged in
the Q175 ChIs (WT median: 11.0 pA, n = 7 neurons,
N = 2 mice; Q175+/− median: 9.6 pA, n = 8 neurons,
N = 2 mice, P > 0.6, two tailed Wilcoxon rank-sum test,
Figure 3).
Next, the input-output relationship of the cortical response
in ChIs was estimated using light pulses of increasing intensity
(Figure 4A). As the light intensities grew, the EPSC amplitude
in ChIs from 2 to 3-month old Q175 mice rose more than in
WT littermates (WT: n = 7 neurons, N = 3 mice; Q175+/−:
n = 6 neurons, N = 3 mice, P < 0.001, ANCOVA, Figure 4A).
The elevation in Q175 ChI responses to cortical stimulation
also was evident when a short burst of optical stimuli (20 Hz,
10 pulses) was used and the evoked discharge rate measured in
cell-attached mode. The enhanced synaptic response led to an
increase in spiking. In ChIs from 4-month old WT mice, bursts
of cortical activity only modestly increased the probability of ChI
spiking, whereas in ChIs from Q175+/− mice, the same stimuli
evoked robust spiking (WT median: 6.4 spikes/s, n = 7 neurons,
N = 4 mice; Q175+/− median: 11.8 spikes/s, n = 7 neurons,
N = 3 mice, P < 0.05, two tailed Wilcoxon rank-sum test)
that was often followed by a pause in activity, as previously
described to occur following thalamic stimulation (Ding et al.,
2010; Figure 4B).
FIGURE 3 | Light-driven minimal stimulation of cortico-striatal
synapses onto ChIs in the Q175 mouse. (A) Measurement of unitary
EPSCs using a minimal stimulation protocol where the presence (black traces)
or absence (gray) of a response is stochastic (note the compound action
potential due to synchronous activation of ChR2-laden corticostriatal axons
that is visible in both cases). (B) Empirical probability density function of the
unitary EPSC amplitude is fit by a binomial mixture-of-Gaussians model of the
minimal synaptic responses and failures in wildtype (black trace) and Q175+/−
(gray trace) mice. (C) Boxplot of the value of the 2nd mode of the mixture in
both genotypes.
Nav1 Channels were Necessary for
Amplification of Cortical Input
The enhanced cortical response in Q175 ChIs was not dependent
upon NMDA receptors, as all EPSC measurements and spiking
responses were conducted while bathing the slices in the NMDA
receptor antagonist D-APV (50 µM).We therefore hypothesized
that Nav1 channels could give rise to the amplification, as
in neocortical pyramidal neurons (Schwindt and Crill, 1995).
Indeed, when QX-314 (a membrane impermeable antagonist
of Nav1 channels) was included in the pipette, the EPSC
amplitudes in ChIs from 2 to 3-month old Q175 mice
normalized and were no longer distinguishable from those
evoked in WT mice (WT: n = 6 neurons, N = 2 mice;
Q175+/−: n = 6 neurons, N = 2 mice, P > 0.65, ANCOVA,
Figure 5A).
Another inward conductance in the same voltage range in
ChIs that may be susceptible to QX-314 block is attributable to
Cav1.3 Ca2+ channels (Yan and Surmeier, 1996; Goldberg and
Wilson, 2005; Goldberg et al., 2009); however, the Cav1 channel
antagonist isradipine (5 µM) had no effect on EPSC amplitude
(data not shown). To further assess whether Nav1 channels were
responsible for amplification of cortical inputs in ChIs, optically
evoked EPSCs were measured in the presence of ranolazine,
which preferentially antagonizes Nav1 channels in the persistent
gating mode (Antzelevitch et al., 2004; Abrams et al., 2006).
Bath application of ranolazine (30 µM) significantly reduced
the amplitude of cortical EPSCs evoked by strong stimulation
in 4-month-old Q175 mice (WT median: 284 pA; Q175+/−,
ranolazine median: 200 pA, n = 8 neurons, N = 3 mice,
P < 0.01, two tailed Wilcoxon signed-rank test, Figure 5B).
Moreover, ranolazine reduced the ability of cortical stimulation
to evoke spikes. In cell-attached mode, the spiking elicited
by optical stimulation of corticostriatal axons was reduced
relative to that seen prior to ranolazine application (Figure 5C),
demonstrating that reducing the persistent-Nav1 dependent
boosting of synaptic input translated into a reduced spiking
response to cortical activation.
To determine if Nav1 channel currents were greater in
Q175 ChIs, neurons were patch clamped using an internal
solution containing cesium to block K+ channels and improve
voltage control of dendrites. Because transient Nav1 channel
currents in the dendrites could not be clamped (even with a
cesium internal solution), long (800 ms) voltage steps from
–60 mV were delivered to measure persistent currents; TTX was
then applied and the TTX-sensitive part of the current computed
by subtraction (Figure 5D; Bennett et al., 2000). Persistent Na+
currents measured in this way were significantly larger in ChIs
from 2 to 3-month old Q175 mice than in WT littermates ; at
–40 mV, the currents in Q175 ChIs were about 25% larger than
those in wildtype ChIs (wildtype: n = 14 neurons, N = 2 mice;
Q175+/−: n = 15 neurons, N = 3 mice, P < 0.01, ANCOVA,
Figure 5E).
To provide an alternative test of whether dendritic Na+
channels were up-regulated in Q175 ChIs, the ability of
somatically generated bAPs to invade the dendrites was
examined using 2PLSM and the Ca2+ dye Fluo-4 in ex vivo
brain slices; in these experiments, Ca2+ entry through voltage-
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FIGURE 4 | Strong cortical stimulation augmented EPSCs and excitations of ChIs in the Q175 mouse. (A) Left: EPSCs of increasing size in response to
increasing LED intensity. Right: summary graph of EPSC amplitude as a function of LED intensity in wildtype (WT) (black trace) and Q175+/− (gray trace) mice.
(B) Left: example trace and raster plot of spiking responses in ChIs to trains (20 Hz) of LED pulses in WT (black) and Q175+/− (gray) mice. Right: boxplot of
amplitude of evoked spiking responses in ChIs (measured during the duration of the LED pulse train) in both genotypes.
dependent Ca2+ channels was used as a surrogate measure of
dendritic depolarization driven by Na+ channels. In ChIs from
2 to 3-month old WT mice, bAP-evoked Ca2+ transients were
observed only in the proximal parts of the dendritic arbor.
However, in ChIs from littermate Q175 mice, the bAP-evoked
Ca2+ transients invaded distal dendrites (WT median ratio of
areas under 1F/F0 curves: 0.068, n = 13 neurons, N = 5 mice;
Q175+/−median ratio of areas: 0.330, n = 5 neurons,N = 4mice,
P < 0.05, two tailed Wilcoxon rank-sum test, Figure 6),
consistent with the proposition that there was an up-regulation
in dendritic Nav1 Na+ channels.
Pacemaking Rate was Unchanged in
Q175 ChIs
Nav1 Na+ currents are necessary for pacemaking in ChIs
(Bennett et al., 2000; Maurice et al., 2004), and as shown above
(Figure 5C), antagonizing the persistent-Nav1 current indeed
slows and eventually stops pacemaking. Hence, it is possible
that the up-regulation in Nav1 channel currents (Figure 5E)
could increase pacemaking rate. However, measurement of the
autonomous in vitro firing rate of ChIs from 2 to 4-month old
mice in the cell-attached mode (which preserves the intracellular
milieu) revealed no difference between wild type and Q175 ChIs
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FIGURE 5 | Boosting of cortical input to ChIs depends of post-synaptic
Nav1 channels that are upregulated in Q175 mice. (A) Examples of
EPSCs and dependence of their amplitude on LED intensity measured with
5 mM QX-314, a membrane impermeable Nav channel antagonists, in the
recording pipette in wildtype (WT, black) and Q175+/− (gray) mice.
(B) Example of a light-driven EPSC and dependence of their amplitude on
LED intensity before (black) and after (gray) ranolazine (30 µM). (C) Population
peri-stimulus time histogram before (gray) and at least 5 min after (black)
application of ranolazine. (D) Measurement of persistent TTX-sensitive inward
currents in cesium loaded ChIs, in response to 800-ms-long voltage pulses (to
−60 mV, −50 mV and −40 mV, color coded). (E) Persistent Nav1 current as a
function of voltage in both genotypes.
FIGURE 6 | Back-propagating action potentials (bAPs) infiltrate further
into distal dendrites of ChIs in Q175 mice, as measured by 2PLSM
Ca2+ imaging. (A) Dendritic Ca2+ transients elicited by brief 2 nA somatic
current pulses measured at three distances from the soma in wildtype (WT)
and Q175+/− mice beneath 2PLSM Z-stacks of the recorded cells.
(B) Boxplot of the area beneath the 1F/F traces (e.g., depicted in the shaded
area in bottom left trace) at the distal location divided by the area beneath the
1F/F traces at the proximal location.
(WTmedian: 1.16 spikes/s, n = 17 neurons,N = 6mice; Q175+/−
median: 2.28 spikes/s, n = 32 neurons, N = 6 mice, P > 0.28, two
tailed Wilcoxon rank-sum test, Figure 7A).
As pacemaking is readily seen in acutely dissociated ChIs
that lack distal dendrites (Maurice et al., 2004), the ion
channels responsible for its generation are localized to the
proximal, somatodendritic compartment, including the axon
initial segment. In this subcellular region, Kv4 K+ channels
are known to make a major contribution to determining
pacemaking rate (Song et al., 1998). Up-regulation in these
channels could counteract the functional increase in Nav1 Na+
channel currents, leading to a normalization of pacemaking
rate. To test this possibility, the properties of Kv4 channel
currents were measured in ChIs (Figure 7B). While there
was no difference in peak Kv4 channel currents or activation
voltage-dependence, there was a significant rightward shift in
inactivation voltage-dependence of Kv4 channels in Q175 ChIs
(WT median half inactivation voltage: –68.6 mV, n = 4 neurons,
N = 1 mouse; Q175+/− median half inactivation voltage:
–58.2 mV, n = 5 neurons, N = 2 mice, P < 0.05, two
tailed Wilcoxon rank-sum test, Figure 7C). This shift should
increase outward Kv4 channel K+ window currents during
pacemaking, counter-balancing the augmentation of inward
Nav1 Na+ currents.
DISCUSSION
Three conclusions can be drawn from our studies about the
striatal adaptations in presymptomatic Q175+/− mice. First,
the autonomous spiking of ChIs was not significantly changed.
Second, the release probability of thalamostriatal glutamatergic
synapses to ChIs was altered. Third, the response of ChIs to
strong stimulation of the cerebral cortex axons was enhanced;
this enhancement was attributable to amplification of synaptic
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FIGURE 7 | Autonomous firing rate of ChIs is unchanged in the Q175 mouse. (A) Boxplots of autonomous firing rates recorded in the cell-attached mode in
wildtype (WT, black) and Q175+/− (gray) mice. (B) Representative traces of A-type K+ current recorded at +20 mV after a series of hyperpolarizing steps in WT
(black trace) and Q175+/− (gray trace) mice. (C) Left: inactivation curves of A-type current in both genotypes. Right: boxplots of the half-inactivation voltage (Vh) in
both genotypes.
responses by post-synaptic voltage-dependent Nav1 channels.
Taken together, these results suggest that the striatal circuitry
is ‘‘re-wired’’ by mHtt, shifting control of ChI activity away
from the thalamus and toward the cerebral cortex. This shift
could have profound effects on the cholinergic modulation of the
striatal circuit and movement control.
Excitatory Synaptic Control of ChIs was
Altered in HD Models
This reduction in the PPR of the thalamostriatal synapses onto
ChIs is consistent with an increased release probability. This
could be a compensation for a reduction in the total number
of thalamostriatal synapses in the Q175 mouse (Deng et al.,
2013; Deng and Reiner, 2016). There is evidence from human
HD patients that ILN neurons are lost (Heinsen et al., 1996;
Kassubek et al., 2005). However, because of variation in the
infection of PFN neurons responsible for this projection, it
was not possible to reliably determine whether there was in
fact a reduction in the functional connectivity of ChIs with
PFN in the Q175 model. Alternative strategies, like transgenic
mice in which PFN neurons selectively express ChR2 or Cre
recombinase, should allow this question to be definitively
answered.
The clearest change observed was the amplification of
Q175 ChIs responses to strong cortical stimulation. The
enhanced responses originated in the postsynaptic membrane, as
there was no discernible change in glutamate release probability
or in the amplitude of unitary synaptic currents at cortical
synapses. Amplification was seen only with strong synaptic
depolarization that was capable of engaging voltage-dependent
Nav1 Na+ channels and was eliminated by dialysis with
QX-314, a lidocaine derivative that antagonizes Na+ channels
(Strichartz, 1973) and by ranolazine, a selective antagonist
of the ‘‘late’’ Na+ current (Abrams et al., 2006). Although
Nav1 Na+ channel availability could not be directly estimated
because of limitations in the ability of a somatic electrode
to clamp rapidly gating dendritic channels, persistent Na+
current was larger in HD ChIs. Persistent Na+ current is due
to a re-opening gating mode of Nav1 channels (Cantrell and
Catterall, 2001; Carr et al., 2003); the molecular architecture
of the Nav1 channel determines the probability of this gating
mode, as different subunit combinations result in persistent Na+
current constituting from 1% to 5% of the peak transient current
(Aman et al., 2009). The subunits contributing to Na+ currents
in ChIs are heterogeneous, possibly reflecting differences in their
localization within different subcellular compartments (Maurice
et al., 2004). The lack of change in autonomous firing rates in
the Q175 suggests that the upregulation of Na+ channels is not
axosomatic. However, our finding that bAPs propagate farther
into the dendritic arbor of the ChIs, supports the notion that
the upregulation is largely dendritic, leading to amplification of
cortical synapses located there.
Functional Implications for the
Pathophysiology of HD
There are several lines of evidence suggesting that
hypocholinergic signaling in the striatum is a potentially
important feature of early stage HD. A number of markers
of cholinergic signaling—AChT, vACh, and MRs—are
down-regulated in HD or models of HD (Enna et al., 1976;
Wastek and Yamamura, 1978; Cha et al., 1998; Smith et al.,
2006).
Our studies add a new dimension to this body of work,
showing that the integration of excitatory synaptic inputs by ChIs
is significantly altered in the Q175 model. Although it remains
unclear whether the total synaptic input to ChIs from PFNs is
altered, what was clearly different in the Q175 ChIs was their
sensitivity to high frequency PFN spiking or bursting. Burst
spiking in PFN occurs in response to behaviorally salient stimuli
(Minamimoto and Kimura, 2002; Minamimoto et al., 2009),
leading to enhanced activity in striatal indirect pathway SPNs
(iSPNs) and suppression of movement. This ‘‘stop and look’’
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response should be impaired in Q175 mice and in HD patients,
potentially contributing to early stage hyperkinetic symptoms.
Recent work demonstrating that GABAergic synaptic inputs to
ChIs are up-regulated in the R6/2 model (Holley et al., 2015)
provides a complementary mechanism by which the temporal
pattern of ChI activity might be disrupted in HD.
An impairment in PFN activation of ChIs in response
to salient or rewarding stimuli also could lead to deficits
in synaptic plasticity. ChI controlled M1 muscarinic receptor
stimulation is critical to long-term potentiation of glutamatergic
synapses controlling appropriately timed and scaled iSPN activity
necessary for movement suppression (Picconi et al., 2006;
Wang et al., 2014). In direct pathway SPNs (dSPNs), phasic
ChI activation of M4 muscarinic receptors counter-balances
D1 dopamine receptor signaling (Onali and Olianas, 2002;
Hernández-Flores et al., 2015), promoting long-term depression
of cortical excitatory glutamatergic synapses (Shen et al., 2015).
Thus, a deficit in thalamic PF control of ChIs could lead to
attenuation of excitatory synapses on iSPNs and enhancement
of excitatory synapses on dSPNs, again, contributing to the
hyperkinetic symptoms characteristic of early stage HD.
What is less apparent is how amplification of cortical inputs to
ChIs would alter network function. Recent mapping of cortical
synaptic connections made on ChIs suggests that these arise
primarily from cingulate cortex (unpublished observations). Like
the ILN, cingulate cortex neurons are robustly activated by salient
environmental events (Dean et al., 2004; Manza et al., 2016).
Thus, the up-regulation of this input in HD models may be a
compensatory response to the loss of ILN inputs (Heinsen et al.,
1996; Kassubek et al., 2005; Deng et al., 2013; Deng and Reiner,
2016).
Our results and those of others suggest that inappropriately
timed or scaled ChI activity could contribute to the hyperkinetic
features of early stage HD. This insight opens several potential
therapeutic avenues. Systemically administered M4 muscarinic
receptor positive allosteric modulators (PAMs), which might
partially compensate for diminished thalamic drive of ChIs in
HD, have been shown to blunt unwanted movement evoked by
levodopa treatment (Shen et al., 2015). Similarly, M1 muscarinic
receptor PAMs might be effective in boosting event-driven ChI
enhancement of iSPN activity, enabling suppression of unwanted
activity. Alternatively, nicotinic receptor agonists might be
effective in modulating striatal cholinergic signaling through
GABAergic interneurons and dopaminergic terminals and in so
doing suppress hyperkinetic symptoms in early stage HD (Quik
et al., 2014).
Summary
Our studies demonstrate that in presymptomatic Q175 mice,
the functional connectivity between thalamic PFN neurons
and ChIs is attenuated, resulting in amplification of cortical
responsiveness. This amplification was due to amplification of
dendritic voltage-dependent Nav1 channels. Thus, there is a
functional ‘‘re-wiring’’ of the striatal networks in HD models,
which results in greater cortical control of phasic ChI activity,
which is widely thought to shape the impact of salient stimuli on
striatal action selection.
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